Amarin Corporation plc - Special Call Transcript
Greetings, and welcome to Amarin's discussion on Transforming the Unprecedented REDUCE-IT Study Results into Clinical Practice. (Operator Instructions) It is now my pleasure to introduce Elisabeth Schwartz, Senior Director of Investor Relations for Amarin. Please go ahead, Elisabeth.
Thank you. Welcome to today's discussion on Transforming the Unprecedented REDUCE-IT Study Results into Clinical Practice. The slides accompanying this call are on our Investors section of www.amarincorp.com. If interested in (inaudible), please reference the forward-looking statements section in the reference slide on Amarin's website.
I would like to turn the call over to Dr. Craig Granowitz, the Chief Medical Officer of Amarin.
Thank you, Elisabeth, and thank you all to our panelists and the listeners who called
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |